.png)
Agenzia Italiana del Farmaco
home
Highlights
-
04 Sep 2025
Fight of pharmaceutical crime
Warning about the rise in illegal medicines sold in the EU as GLP-1 receptor agonists
AIFA reiterates that the structure of the national legal production and distribution chain makes it virtually impossible for counterfeit products to infiltrate the market, as they are only distributed through illegal channels such as unauthorised websites and platforms. Purchasing these products is dangerous and poses a serious health risk.
-
07 Aug 2025
AIFA Notes
Revision of AIFA Notes: repeal of Notes 2, 4 and 41
As of 7 August 2025, AIFA Notes 2, 4 and 41 are repealed.
-
30 Jul 2025
Press releases
AIFA monitoring of final data for January-December 2024
Pharmaceutical expenditure for direct purchases by the Regions exceeds the budget by 4 billion.
-
29 Jul 2025
Press releases
IThe AIFA Board of Directors approves the reimbursability of 11 medicines, including the first gene therapy for haemophilia B
The National Health Service will reimburse the first one-shot treatment for severe and moderately severe haemophilia B, a rare and potentially fatal disease that causes bleeding in the joints, muscles and internal organs.
News
03 Sep 2025
The Agency
Interruption of the telephone switchboard service and the Farmaci-Line toll-free number
05 Sep 2025
Safety of medicinal products
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-4 September 2025
05 Sep 2025
Medicine shortages
Direct communication with healthcare professionals on Victoza
29 Aug 2025
Quality and Inspections
Direct communication with healthcare professionals on Lipidem
22 Aug 2025
Medicine shortages
Direct communication with healthcare professionals on supply shortage Zypadhera
21 Aug 2025
Quality and Inspections
Direct communication with healthcare professionals on Evrysdi
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
